Db Foot Pain Relieving Spray
NDC Package 43689-0070-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Db Foot Pain Relieving (apis mellifica, gelsemium sempervirens, gnaphalium) sprays is classified as a

administered via topical route. This formulation utilizes a spray delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0070.

Identification & Billing

NDC Package Code
43689-0070-3
Package Description
85 g in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
43689007003

Clinical Specifications

Proprietary Name
Db Foot Pain Relieving
Non-Proprietary Name
Apis Mellifica, Gelsemium Sempervirens, Gnaphalium
Substance Name
Apis Mellifera; Gelsemium Sempervirens Whole; Pseudognaphalium Luteoalbum Leaf
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Regulatory & Marketing

Labeler Name
The Magni Company
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
12-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43689-0070-3 identifies a specific commercial package of 85 g in 1 bottle, spray of Db Foot Pain Relieving, a human over the counter drug labeled by The Magni Company. This spray is formulated for topical use and contains apis mellifera; gelsemium sempervirens whole; pseudognaphalium luteoalbum leaf as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on December 01, 2025. The current certification is valid through December 31, 2027.

How is this The Magni Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689007003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43689-0070-3
11-Digit CMS (5-4-2)
43689-0070-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.